Advertisement

Topics

Shire says trial shows new HAE drug significantly reduces attacks

03:49 EDT 11 Sep 2017 | Reuters

LONDON (Reuters) - London-listed drugmaker Shire said on Monday it had successfully tested a new medicine that prevents attacks in patients with hereditary angioedema (HAE), a rare genetic disease that causes swelling of extremities, the gastrointest...

Original Article: Shire says trial shows new HAE drug significantly reduces attacks

NEXT ARTICLE

More From BioPortfolio on "Shire says trial shows new HAE drug significantly reduces attacks"

Quick Search
Advertisement